SCHEMBL24259751

SCHEMBL24259751

CC(C)CCNC(=O)[C@H]1CCC[C@H]1NC(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.47
GAA P10253 1/20 0.45
RAB9A P51151 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
PSEN1 P49768 4/20 0.41
PSEN2 P49810 4/20 0.41
APH1B Q8WW43 4/20 0.41
NCSTN Q92542 4/20 0.41
APH1A Q96BI3 4/20 0.41
PSENEN Q9NZ42 4/20 0.41
MMP2 P08253 1/20 0.40
MMP8 P22894 1/20 0.40
ALDH1A1 P00352 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
MAPT P10636 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
EPHX2 P34913 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22134431 0.86 GRM4 (0.45) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL20287581 0.84 GAA (0.42) HSD17B10GAARAB9ASMN1; SMN2PSEN1
SCHEMBL20286452 0.84 GAA (0.42) HSD17B10GAARAB9ASMN1; SMN2PSEN1
SCHEMBL26212331 0.81 GAA (0.51) HSD17B10GAARAB9ASMN1; SMN2MMP2
SCHEMBL25785457 0.76 PSEN1 (0.41) HSD17B10GAASMN1; SMN2PSEN1PSEN2
SCHEMBL12384303 0.76 HSD17B10 (0.62) HSD17B10GAARAB9ASMN1; SMN2MMP2
SCHEMBL6385930 0.73 HSD17B10 (0.62) HSD17B10GAARAB9ASMN1; SMN2MMP2
SCHEMBL7750667 0.72 HSD17B10 (0.66) HSD17B10GAARAB9ASMN1; SMN2MMP2
SCHEMBL15592763 0.72 ACE (0.46) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL19091400 0.72 ACE (0.46) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3432934-B1 PRODRUGS OF CYTOTOXIC AGENTS WITH ENZYMATICALLY CLEAVABLE GROUPS Bayer Pharma AG (DE) 2022-02-23 EP disclosed